GovChime
Archived

Department of Defense Pharmacy Uniform Formulary Blanket Purchase Agreement / Uniform Formulary Additional Discount Program

Overview

Response deadline
12:00 PM CDT
Posted
October 22, 2025
Notice type
Solicitation
Set-aside
No Set aside used
Agency
Department of WarDEFENSE HEALTH AGENCY (DHA)

Notice details

Office
DEFENSE HEALTH AGENCY
Place of performance
San Antonio, Texas, 78230
Last updated
Nov 6, 2026
First published
Last updated on SAM.gov

Identifiers

Solicitation number
HT9402-25-Q-9404
Notice ID
41d1ca6915d8421ea65f49a0de162da5

Description

The Department of Defense (DoD) is required by law (10 U.S.C. § 1074g) to establish an effective, efficient, integrated pharmacy benefits program for the Military Health System (MHS) which includes the purchase pharmaceutical agents. The law and implementing regulation (32 CFR Section 199.21) describe the process by which the DoD Pharmacy and Therapeutics (P&T) Committee will consider the relative clinical effectiveness and relative cost effectiveness of pharmaceutical agents in a therapeutic class in recommending the selection of agents for the DoD Uniform Formulary (UF) and, for cost sharing purposes, the classification of a pharmaceutical agent as generic, formulary, Basic Core Formulary (BCF), Extended Core Formulary (ECF), or non-formulary (NF). Prior to the scheduled P&T Committee meeting, a Request for Quotation (RFQ) for pharmaceutical agents within Drug Classes identified for placement on the UF has been issued to obtain quotes from industry. The Defense Health Agency may award Uniform Formulary Blanket Purchase Agreements (UF BPA) and the Uniform Formulary Additional Discount Program Agreements (UF ADP) based on the UF decision. This process is described in the attached RFQ.

P&T COMMITTEE MEETING: The following November 2025 newly approved drugs will be reviewed:

a. Blujepa - Antibiotics - N/A
b. Brekiya - Migraine Agents - N/A
c. Dawnzera - Corticosteroids-Immune Modulators - Hereditary Angiodema Agents
d. escitalopram - Antidepressants and Non-opioid Pain Syndrome Agents - Selective Serotonin Reuptake Inhibitors
e. Exxua - Antidepressants and Non-opioid Pain Syndrome Agents - N/A
f. Leqembi IQLIK - Alzheimers Agents - N/A
g. ustekinumab-ttwe - Targeted Immunomodulatory Biologics - Interleukin 23
h. Wayrilz - Hematological Agents - Platelets
i. Zurnai - Alcohol Deterrants-Narcotic Antagonists - Narcotic Antagonists
j. Phyrago - Oncological Agents - Chronic Myelogenous Leukemia
k. Inluriyo - Breast Cancer Agents - Estrogen Receptor Antagonist
l. Enbumyst - Diuretics - N/A

The RFQ, including UF BPA and UF ADP appendices are attached here in. The instructions, important deadlines, and points of contact are in document, RFQ HT9402-25-Q-9404.

Pre-quotation teleconference is on October 15, 2025. Details are stated in Part 2.4. Pre-Quotation Teleconference. Responses to the clinical questions in Part 3.4 shall be submitted via e-mail to the RFQ POC in Part 2.3.1., no later than the date stated in Part 2.3.2.

Full description on SAM.gov

Award Overview

No prior contract identified

No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.

Contacts

Contracting Officer

Primary Contact

Documents

Files (17)

  • Amendment 0001.pdf

    143 KBAdded in Solicitation version 3Posted
    Download
  • A0001 Price List - Inluriyo - Breast Cancer Agents - ERA.xlsx

    46 KBAdded in Solicitation version 3Posted
    Download
  • RFQ HT9402-25-Q-9404 NAD.pdf

    2.7 MBAdded in Solicitation version 1Posted
    Download
  • Price List - Blujepa - Antibiotics - NA.xlsx

    46 KBAdded in Solicitation version 1Posted
    Download
  • Price List - Brekiya - Migraine Agents - NA.xlsx

    46 KBAdded in Solicitation version 1Posted
    Download
  • Price List - Dawnzera - CIM - Hereditary Angioedema Agents.xlsx

    46 KBAdded in Solicitation version 1Posted
    Download
  • Price List - escitalopram - Antidepressants Non-opioid Pain SYN - SSRI.xlsx

    47 KBAdded in Solicitation version 1Posted
    Download
  • Price List - Exxua - Antidepressants Non-opioid Pain SYN - NA.xlsx

    47 KBAdded in Solicitation version 1Posted
    Download
  • Price List - Leqembi IQLIK - Alzheimers Agents - NA.xlsx

    46 KBAdded in Solicitation version 1Posted
    Download
  • Price List - ustekinumab-ttwe - TIB - Interleukin 23.xlsx

    50 KBAdded in Solicitation version 1Posted
    Download
  • A-3 Price List - Wayrilz - Hematological Agents - Platelets.xlsx

    46 KBAdded in Solicitation version 1Posted
    Download
  • Price List - Zurnai - Alcohol Deterrants-Narcotic Antagonists - Narcotic Antagonists.xlsx

    46 KBAdded in Solicitation version 1Posted
    Download
  • Price List - Phyrago - Oncological Agents - Chronic Myelogenous Leukemia.xlsx

    46 KBAdded in Solicitation version 1Posted
    Download
  • Price List - Inluriyo - Oncological Agents - NA.xlsx

    46 KBAdded in Solicitation version 1Posted
    Download
  • Price List - Enbumyst - Diuretics - NA.xlsx

    46 KBAdded in Solicitation version 1Posted
    Download
  • Price Appendix FAQ NAD.pdf

    231 KBAdded in Solicitation version 1Posted
    Download
  • DoD Formulary Placement of FDA Newly Approved Drugs.pdf

    83 KBAdded in Solicitation version 1Posted
    Download

Lifecycle

  1. 1
    Version 1SolicitationArchived

    Department of Defense Pharmacy Uniform Formulary Blanket Purchase Agreement / Uniform Formulary Additional Discount Program

    Notice dc342dd8870d4d0db0a16525ddaa645d on SAM.gov

  2. 3
    Version 3SolicitationArchivedCurrent

    Department of Defense Pharmacy Uniform Formulary Blanket Purchase Agreement / Uniform Formulary Additional Discount Program

    Notice 41d1ca6915d8421ea65f49a0de162da5 on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline

Additional Details

Solicitation Number

HT9402-25-Q-9404

Archive Date

Apr 27, 2026

Office Address

AURORA, CO, 80011